February 4th, 2012
(APDN.OB) Applied DNA Sciences Moves Forward Within Government, Banking, And Insurance Industries
Posted on 16. Mar, 2011 by PublicWire
(PublicWire.com News Release) Applied DNA Sciences, Inc. (OTCQB:APDN), announces new customers and inquiries within the governments and the banking and insurance industries.
Applied DNA provides DNA markers to protect cash and valuables in transit (CViT), to protectbrand owners, and to secure legitimate supply chains against the diversion to gray markets and against the infiltration of counterfeit products. The company’s approach to each vertical market has been to sell its unique, uncopyable DNA tags to suppliers whose components enter at the bottom or through multiple points within a supply chain, and then license the platform to “pain
points” that experience the most liability.
Licensing Model Similar to Software Industry
For example, within the cash transportation industry, APDN sells its DNA markers to the security ink users, ATM cassette manufacturers, and cash box manufacturers, who supply their DNA-enhanced products to security companies and ATM owners. However, the security value in the event of theft can only be realized if the risk-owner has licensed the platform from APDN.
License Unlocks the DNA Sequence Key
“Our model is similar to that employed by the software industry,” said Dr. James Hayward, CEO of APDN. “We ensure widespread deployment of our DNA marks within an industry, in the same manner as software developers distribute software via laptops and device manufacturers. Our licensees can only realize the value of the DNA markers, just as software must be licensed to enjoy its value.” He continued: “Our DNA sequence content is only available to our licensees.
We maintain control of our sequences, and only we can authenticate the cash stolen and provide forensic support in an act perpetrated against a risk-owner, which is initially the cash-intransit transporter, but ultimately includes the financial institution and their insurer.”
APDN now has a proven track record within the CViT industry. With over 22 convictions to its credit, APDN has a 100% conviction record for captured criminals who have stolen cash from its security licensees within the UK. The result, the deterrence provided by APDN, yielded a significant drop in attacks and eliminated cash losses more than one hundred times the cost of annual licensing.
Proven Return on Investment
This proven ROI has brought APDN customers higher up the risk chain. “Banks, insurers and governments are now recognizing the deterrence that can only be provided by DNA markers,” said Dr. Hayward. “We have received initial orders from governments and insurers, and we are fielding inquiries from banks internationally. The increased demand contributed to the closing of the best quarter in our company’s history, announced in SEC filings that describe our first FY11 quarter, ending December 2010.”
About APDN
APDN sells patented DNA security solutions that provide anti-counterfeit protection, as well as protecting brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used for product authentication in a unique manner that essentially cannot be copied. When used in conjunction with other law enforcement technologies, SigNature DNA can provide a forensic chain of evidence that has been used successfully in more than 22 convictions. To learn more, go to www.adnas.com where APDN routinely posts all press releases.
The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to ur short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K, filed on December 15, 2010 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
SOURCE Applied DNA Sciences, Inc.
INVESTOR CONTACT: Debbie Bailey, 631-444-8090, fax: 631-444-8848
MEDIA CONTACT: Janice Meraglia, 631-444-6293, fax: 631-444-8848
FCMN Contact: info@adnas.com
Web site: http://www.adnas.com
Trading Symbols
Applied DNA Sciences trades Over The Counter As APDN (OTCBB:APDN, APDN.OB, APDN.OTCBB, APDN)
About PublicWire.com
PublicWire.com is a Small Cap Financial Press Release Company that uses a variety of cutting edge methods to syndicate your Small Cap Press Release to various news and information outlets. Our press releases have consitantly placed the Small Cap Companies we work with on the first result page of major search engines such as Google, Bing, and Yahoo. We work exclusively with Pinksheet and Over The Counter (PK and OTCBB) Companies to ensure maximum exposure for their Press Releases.
To maximize your OTCBB / Pinksheet / Small Cap Company Press Release, call us directly at 407-218-7446.
OTCBB:APDN, APDN.OB, APDN.OTCBB, APDN
The symbols “OTCBB:APDN, APDN.OB, APDN.OTCBB, APDN” reflect the variety of methods APDN lists their stock as, and were valid at the time of original publication of this press release.
(PublicWire.com News Release) Applied DNA Sciences, Inc. (OTCQB:APDN), announces new customers and inquiries within the governments and the banking and insurance industries.
Applied DNA provides DNA markers to protect cash and valuables in transit (CViT), to protectbrand owners, and to secure legitimate supply chains against the diversion to gray markets and against the infiltration of counterfeit products. The company’s approach to each vertical market has been to sell its unique, uncopyable DNA tags to suppliers whose components enter at the bottom or through multiple points within a supply chain, and then license the platform to “pain
points” that experience the most liability.
Licensing Model Similar to Software Industry
For example, within the cash transportation industry, APDN sells its DNA markers to the security ink users, ATM cassette manufacturers, and cash box manufacturers, who supply their DNA-enhanced products to security companies and ATM owners. However, the security value in the event of theft can only be realized if the risk-owner has licensed the platform from APDN.
License Unlocks the DNA Sequence Key
“Our model is similar to that employed by the software industry,” said Dr. James Hayward, CEO of APDN. “We ensure widespread deployment of our DNA marks within an industry, in the same manner as software developers distribute software via laptops and device manufacturers. Our licensees can only realize the value of the DNA markers, just as software must be licensed to enjoy its value.” He continued: “Our DNA sequence content is only available to our licensees.
We maintain control of our sequences, and only we can authenticate the cash stolen and provide forensic support in an act perpetrated against a risk-owner, which is initially the cash-intransit transporter, but ultimately includes the financial institution and their insurer.”
APDN now has a proven track record within the CViT industry. With over 22 convictions to its credit, APDN has a 100% conviction record for captured criminals who have stolen cash from its security licensees within the UK. The result, the deterrence provided by APDN, yielded a significant drop in attacks and eliminated cash losses more than one hundred times the cost of annual licensing.
Proven Return on Investment
This proven ROI has brought APDN customers higher up the risk chain. “Banks, insurers and governments are now recognizing the deterrence that can only be provided by DNA markers,” said Dr. Hayward. “We have received initial orders from governments and insurers, and we are fielding inquiries from banks internationally. The increased demand contributed to the closing of the best quarter in our company’s history, announced in SEC filings that describe our first FY11 quarter, ending December 2010.”
About APDN
APDN sells patented DNA security solutions that provide anti-counterfeit protection, as well as protecting brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used for product authentication in a unique manner that essentially cannot be copied. When used in conjunction with other law enforcement technologies, SigNature DNA can provide a forensic chain of evidence that has been used successfully in more than 22 convictions. To learn more, go to www.adnas.com where APDN routinely posts all press releases.
The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to ur short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K, filed on December 15, 2010 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
SOURCE Applied DNA Sciences, Inc.
INVESTOR CONTACT: Debbie Bailey, 631-444-8090, fax: 631-444-8848
MEDIA CONTACT: Janice Meraglia, 631-444-6293, fax: 631-444-8848
FCMN Contact: info@adnas.com
Web site: http://www.adnas.com
Trading Symbols
Applied DNA Sciences trades Over The Counter As APDN (OTCBB:APDN, APDN.OB, APDN.OTCBB, APDN)
About PublicWire.com
PublicWire.com is a Small Cap Financial Press Release Company that uses a variety of cutting edge methods to syndicate your Small Cap Press Release to various news and information outlets. Our press releases have consitantly placed the Small Cap Companies we work with on the first result page of major search engines such as Google, Bing, and Yahoo. We work exclusively with Pinksheet and Over The Counter (PK and OTCBB) Companies to ensure maximum exposure for their Press Releases.
To maximize your OTCBB / Pinksheet / Small Cap Company Press Release, call us directly at 407-218-7446.
OTCBB:APDN, APDN.OB, APDN.OTCBB, APDN
The symbols “OTCBB:APDN, APDN.OB, APDN.OTCBB, APDN” reflect the variety of methods APDN lists their stock as, and were valid at the time of original publication of this press release.
Thought-Controlled Game; Jedi Mind, Inc. (JEDM.PK) Provides Update on Progress
Posted on 23. Nov, 2009 by PublicWire in Medical
23 November 2009 (PublicWire) — Jedi Mind, Inc. (Pink Sheets: JEDM) (www.jedimindinc.com), a thought-controlled and mind-controlled gaming and medical applications Company, today provided an update to shareholders regarding the developments of the Company, new products coming out and the airing of “Inside Business” featuring Jedi Mind, Inc. on CNBC and CNN Headline News.
The Company is working on multiple applications being developed for the gaming industry as well as for medical applications. The first game is complete and going through testing for reliability prior to offering it for sale to the public. The Company expects to be finished any day now, with an immediate release of the game to follow. The screen shots of the game are available at www.JediMindInc.com.
The initial application is intended to be a simple, introductory level game for a wide demographic of people of all ages to enjoy and was designed to provide cognitive exercise for anyone playing, but is especially beneficial to children with Attention Deficit Disorder (ADD) and the elderly who need to continually use and build their focus and concentration skills. The Company plans to sell the game, “Think-Tac-Toe” online at a price of $49 and will release details regarding where to purchase the game as soon as it is released.
Jedi Mind, Inc. has multiple applications being developed simultaneously, with the first medical application expected to be released in the first quarter of 2010. The Company’s mission is to develop products for the largest markets that take the least amount of time to develop. The Company believes the thought-controlled technology market will present an enormous opportunity for companies on the ground level that own proprietary applications that are used throughout the world in years to come. Jedi Mind, Inc. expects to bring one new product to market every quarter.
On a final note, the Company has been told by the production company that the edited version segment of “Inside Business,” hosted by Fred Thompson should be available next week for review to approve and sign off on. The airing is expected to follow approximately 6 weeks later to over 90 million viewers. The Company expected this to be complete over a month ago, but is excited about the exposure it will receive in the near future.
Safe Harbor:
From time to time, the Company may issue news releases that contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor created by those sections. This material may contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. For those statements, the Company claims the protection of the safe harbor for forward-looking statement provisions contained in the Private Securities Litigation Reform Act of 1995 and any amendments thereto. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be “forward-looking statements.” “Forward-looking statements” are based upon expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those anticipated.